%0 Journal Article
%T Difficult decisions in the cost-effectiveness analysis of new cancer treatments
%A Pax HB Willemse
%A Vivianne CG Tjan-Heijnen
%J European Journal of Oncology Pharmacy
%D 2010
%I Pharma Publishing & Media Europe
%X The value of cancer treatment varies. In The Netherlands ENDO was formed to reach consensus on the value of treatment with a newly developed tool. Professors Willemse and Tjan-Heijnen, former chairs of this committee, together look at the intrinsic difficulties of valuing new cancer treatments.
%U http://www.ppme.eu/Publications/EJOP/Journal-information/Previous-issues/EJOP-Vol.4-2010-Issue-2/Feature/Difficult-decisions-in-the-cost-effectiveness-analysis-of-new-cancer-treatments